IMMUNE CHECKPOINT INHIBITORS
Global Longitudinal Strain and Cardiac Events in Patients With Immune Checkpoint Inhibitor–Related Myocarditis
In a retrospective analysis of the use of global longitudinal strain (GLS) for detection and risk stratification of myocarditis associated with immune checkpoint inhibitor (ICI) therapy, investigators found that GLS decreases with ICI-related myocarditis and is lower among patients with myocarditis presenting with either a preserved or reduced ejection fraction, versus patients who did not experience myocarditis.
American Journal of the College of CardiologyMeet the Faculty
Videos
-
Immune Checkpoint Inhibitors Managing Cardiotoxicity Associated With Immune Checkpoint Inhibitor Therapy
-
Immune Checkpoint Inhibitors Immune Checkpoint Inhibitors and Cardiotoxicity: Incidence and Patient Risk Factors
-
Immune Checkpoint Inhibitors Immune Checkpoint Inhibitors and Cardiotoxicity: The Pharmacist Perspective
